Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Cue Health Inc.

Applied UV is focused on the development and acquisition of technologies that address food security and air and surface pathogen reduction in the healthcare, hospitality, and commercial markets self-described.

Applied UV, Inc.

Visby Medical is a molecular diagnostics company that provides portable PCR testing technology to deliver rapid infectious disease testing for healthcare providers.

Visby Medical

IBS Inc. leverages technology to develop drug testing and biosensor solutions that aim to improve quality of life. Self-described as pioneering pain-free solutions.

IBS Inc.

Cue is a healthcare technology company that develops and manufactures diagnostic devices for at-home and point-of-care use.

Cue is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. Cue's mission is to empower people to live their healthiest lives through personalized, proactive, and informed healthcare.

Cue enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand.

Cue's first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

Fraudulent Recruitment Alert: Please be aware of fraudulent job opportunities and offers not affiliated with Cue Health. For a list of current opportunities, please visit: https://cuehealth.wd1.myworkdayjobs.com/cuehealth

Biomedical Advanced Research and Development Authority (BARDA)

U.S. Department of Defense

U.S. Department of Health & Human Services

Perceptive Advisors

MSD Capital

Johnson & Johnson Innovation – JJDC

Koch Strategic Platforms

Decheng Capital

ACME Capital

CAVU Consumer Partners

Johnson & Johnson

Dentsu Ventures

Madrone Capital Partners

Foresite Capital

Cue Health

Congratulations to Brittany Williams Grieb, Pat Kinshofer, and Aaron Halda for being recognized as our Cue Spotlight winners for November!

Every month, People Managers from across our organization have the opportunity to nominate members of their team for Cue Spotlight, which is our company-wide recognition program for employees who truly exemplify our mission, vision, and values.

Brittany Williams was nominated for building boldly.
Pat Kinshofer was nominated for winning together.
Aaron Halda was nominated for excelling every day.

We appreciate your hard work and dedication to Cue! #WeAreCue

This week members of our Vets & Allies at Cue Employee Resource Group, open to all employees, volunteered at the Veterans Village of San Diego. 

Veterans Village of San Diego (VVSD) has served all Veterans since 1981 and is dedicated to “Leave No One Behind.” Each year VVSD helps thousands of our most vulnerable Veterans to reclaim their lives through programs that offer transitional and permanent housing, mental health counseling, substance use treatment, and employment and training services.

Employees could use their Volunteer Time Off (VTO) for the ERGs first event at VVSD. We're thankful for everyone's help, time, and dedication to help Veterans in need. #WeAreCue #LifeAtCue

California Life Sciences has announced the winners of its 20th annual Pantheon Awards. We are proud to share we won the 2023 Pantheon Award in the Medtech, Digital, & Diagnostic category. 

This year's 20th Annual Award ceremony took place in San Francisco, recognizing and celebrating California’s leading scientific innovators.

“Congratulations to the winners of the 20th Annual Pantheon Awards,” said Mike Guerra, CLS president & CEO. “They are shining examples of dedication to scientific advancement and innovation, and they inspire us to keep pushing boundaries in pursuit of new solutions for patients around the world.”

Read the official California Life Sciences (CLS) press release: http://spr.ly/6049uqTZV #Pantheon2023

Every month, People Managers from across our organization have the opportunity to nominate members of their team for Cue Spotlight. 

Cue Spotlight is our company-wide recognition program for employees who truly exemplify our mission, vision, and values. 

Congratulations to our Cue Spotlight winners from September:
Sydney M. was nominated for winning together.
Joshua Clemente was nominated for winning together.
David Ornelas was nominated for winning together.

Congratulations to our Cue Spotlight winners from October:
Victor Hernandez was nominated for being accountable.
Devin Flanagan was nominated for excelling every day.

We appreciate your hard work and dedication to Cue! #WeAreCue

The risks associated with COVID-19 infection are higher for immunocompromised individuals than the general public. 

If you, or someone you know, is immunocompromised or age 65+, please consider joining the ImmunoCARE study, which provides free molecular COVID-19 tests, telemedicine, and rapid home delivery of medication, if prescribed.

ImmunoCARE is an innovative research project to study whether repeated at-home tests, on-demand telemedicine, and quick delivery of medication for those who test positive for COVID-19 can reduce COVID-19 severity in immunocompromised people.

We are excited to partner with Scripps Research Digital Trials Center on this joint research project and hope you will consider joining us in helping to advance research on COVID-19 outcomes for immunocompromised individuals. 

Click here to see if you or someone you know is eligible to participate: http://spr.ly/6049Z0CPS

If you're experiencing symptoms, you can now gain peace of mind without making a trip to the doctor's office. 

Our molecular COVID-19 test allows you to test from home and receive results on your mobile phone in about 20 minutes. And with options for virtual care and prescription medication delivery, you can stay confident knowing fast, timely access to treatment is available if you ever need it.

Discover how we've made it easy to get the care you need: http://spr.ly/6040ZpMA4

Metric
Company Name	Cue Health Inc.	Applied UV, Inc.	Visby Medical	IBS Inc.
Symbol	HLTH
MSH ID	COM:CUEHEALTH	COM:APPLIEDUVINC	COM:VISBYMEDICAL	INC:IBS
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical - Healthcare Information Services	Disinfection Technology	Medical Devices	Medical Technology
Country	US	US	US	US
Stage		Post-IPO Equity
Employee Count	726			19
Website	cuehealth.com	applieduvinc.com	visbymedical.com	ibs.inc
LinkedIn	cuehealthinc
Founders

Metric
Market Cap	6.90M
Enterprise Value
Monthly Web Traffic		4.16K
Web Traffic Growth		1.24
Valuation
Raised Capital		2.76M

Metric
Revenue	70.94M
Revenue (LTM)
Revenue (NTM)
Gross Profit	-56.16M
EBITDA	-240.44M
Operating Income	-296.71M
Net Income	-373.46M
EPS	-2.44
Diluted EPS	-2.44
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	-0.94
Operating Profit Margin	-4.74
EBITDA Margin	-3.39
Net Profit Margin	-5.67
Return on Equity	-0.96
Return on Assets	-1.09
Return on Capital Employed	-1.05

COM:CUEHEALTH

Cue

Last Close

0.06

05/06 20:00

Market Cap

6.90M

Beta: -

Volume Today

50.91M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.14
P/B Ratio	0.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.46
EV Multiple	-0.02

Metric
Days Sales Outstanding	2.49
Days Payables Outstanding	22.26
Days Inventory Outstanding	48.12
Operating Cycle	50.89
Cash Conversion Cycle	27.73
Asset Turnover	0.19

Metric
Operating Cash Flow	-137.81M
Free Cash Flow	-157.61M
Cash Flow to Debt	-2.87
Operating Cash Flow/Sales	-2.10
Free Cash Flow Yield	-5.33

Metric
Cash & Equivalents	81.69M
Accounts Receivable	17.72M
Inventory	14.04M
Goodwill
Debt to Capitalization	0.16
Debt to Assets	0.10
Current Ratio	3.29
Quick Ratio	1.92

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.28
R&D to Revenue	0.90
SG&A to Revenue	0.34